Pyrazinamide and Rifampin vs Isoniazid for the Treatment of Latent Tuberculosis

Publisher Website

1 January 2003

journal article
research article
Published by Elsevier in Chest

Vol. 123 (1) , 102-106
https://doi.org/10.1378/chest.123.1.102

Abstract

No abstract available

Keywords

This publication has 5 references indexed in Scilit:

Acceptability of Short-Course Rifampin and Pyrazinamide Treatment of Latent Tuberculosis Infection Among Jail Inmates
Chest, 2001
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
American Journal of Respiratory and Critical Care Medicine, 2000
Rifampin and Pyrazinamide vs Isoniazid for Prevention of Tuberculosis in HIV-Infected PersonsAn International Randomized Trial
JAMA, 2000
Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection
The Lancet, 1998
USPHS Tuberculosis Short-Course Chemotherapy Trial 21: Effectiveness, Toxicity, and Acceptability
Annals of Internal Medicine, 1990